BNR
Burning Rock Biotech Ltd
15.20$
+0.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 31.4% | 25.2% | 26.8% | 24.6% | 38.0% | 33.5% | 26.7% | 26.1% | 24.7% | 27.8% | 29.1% | 27.7% | 28.5% | 35.4% | 36.9% | 29.8% | 28.8% | 30.7% | 31.3% | 32.6% | 35.5% | 31.8% | 29.6% | 28.6% | 29.0% | 26.8% | 27.2% | 24.9% | 22.0% | 27.7% | 27.4% | 25.5% | |
| 68.6% | 74.8% | 73.2% | 75.4% | 62.0% | 66.5% | 73.3% | 73.9% | 75.3% | 72.2% | 70.9% | 72.3% | 71.5% | 64.6% | 63.1% | 70.2% | 71.2% | 69.3% | 68.7% | 67.4% | 64.5% | 68.2% | 70.4% | 71.4% | 71.0% | 73.2% | 72.8% | 75.1% | 78.0% | 72.3% | 72.6% | 74.5% | |
| 49.5% | 30.1% | 41.3% | 36.9% | 58.9% | 59.4% | 66.5% | 56.0% | 63.3% | 72.6% | 84.9% | 55.0% | 76.5% | 88.2% | 70.4% | 70.8% | 70.9% | 66.3% | 65.5% | 65.6% | 60.4% | 52.5% | 47.9% | 38.2% | 41.4% | 30.3% | 33.5% | 31.5% | 27.6% | 25.5% | 23.2% | 27.0% | |
| 37.8% | 30.2% | 24.3% | 29.8% | 55.4% | 50.9% | 39.5% | 82.9% | 86.9% | 109.0% | 91.2% | 91.9% | 96.1% | 104.6% | 114.9% | 92.8% | 93.3% | 89.8% | 47.5% | 93.1% | 100.4% | 78.6% | 68.5% | 25.6% | 66.7% | 23.5% | 21.1% | 24.1% | 60.8% | 26.0% | 27.8% | 34.7% | |
| 143.0% | 85.8% | 106.7% | 107.7% | 169.7% | 154.7% | 141.6% | 174.6% | 193.2% | 233.3% | 229.6% | 207.4% | 242.6% | 258.6% | 266.0% | 222.0% | 224.1% | 201.5% | 161.4% | 207.5% | 201.9% | 168.4% | 152.5% | 101.4% | 137.1% | 84.6% | 80.5% | 87.4% | 87.6% | 89.7% | 85.9% | 87.5% | |
| -73.9% | -11.1% | -33.6% | -32.4% | -107.7% | -88.1% | -68.3% | -100.6% | -118.0% | -161.2% | -158.7% | -135.1% | -171.1% | -194.0% | -202.9% | -151.7% | -152.9% | -132.2% | -92.8% | -140.2% | -137.4% | -100.2% | -82.1% | -30.0% | -37.1% | -11.4% | -7.7% | -12.3% | -9.5% | -17.5% | -13.4% | -13.0% | |
| – | 4.0% | 2.2% | 1.6% | – | 1.7% | 1.8% | 0.6% | 0.5% | 0.5% | 0.4% | 0.3% | 0.1% | 1.4% | 0.0% | 1.3% | 2.5% | 2.2% | 0.0% | – | – | – | – | 0.0% | – | 0.0% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -82.6% | -15.2% | -30.7% | -31.0% | -107.2% | -78.1% | -66.4% | -102.6% | -118.8% | -160.8% | -158.7% | -134.3% | -171.2% | -192.9% | -200.3% | -149.7% | -150.7% | -129.7% | -89.4% | -136.8% | -133.1% | -96.6% | -79.6% | -27.6% | -60.3% | -10.0% | -6.4% | -12.6% | -11.5% | -16.0% | -13.4% | -13.3% | |
| 21.7% | 3.9% | -2.3% | -2.0% | -2.5% | -10.3% | -1.9% | 0.1% | 5.8% | -0.3% | 1.3% | 0.3% | -0.8% | -2.5% | 0.1% | -3.3% | 1.3% | 0.3% | 0.3% | 0.4% | 0.9% | 0.1% | 0.1% | 0.2% | – | 0.2% | 0.2% | 0.2% | 0.7% | 0.2% | 0.2% | 0.3% | |
| -104.4% | -15.2% | -30.7% | -31.0% | -107.2% | -78.1% | -66.4% | -102.6% | -118.8% | -160.8% | -160.0% | -134.6% | -170.4% | -192.9% | -200.3% | -149.7% | -152.0% | -130.0% | -89.7% | -137.2% | -134.0% | -96.8% | -79.7% | -27.8% | -64.5% | -10.1% | -6.5% | -12.7% | -12.2% | -16.2% | -13.7% | -13.6% | |
| -65.2% | -4.4% | -28.5% | -28.8% | -106.0% | -64.9% | -61.1% | -94.4% | -112.1% | -153.6% | -150.2% | -127.6% | -163.6% | -184.6% | -177.3% | -142.5% | -129.5% | -108.5% | -68.8% | -113.2% | -122.1% | -70.5% | -79.6% | -2.1% | – | -10.0% | 2.3% | -12.6% | -7.3% | -16.0% | -11.7% | -11.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.